IRCT20211004052664N1 IRCT 2021-10-06 Shahid Beheshti University of Medical Sciences The therapeutic effect of Favipiravir in COVID-19 patients Evaluation of the efficacy of Favipiravir in comparison with standard medication on clinical and laboratory findings of COVID-19 patients with moderate severity 2021-10-31 anticipated 80 Complete https://irct.ir/trial/59137 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method is a simple randomization that is done in the form of individual random units. The tool used to do this is a random numbers table. The method of constructing a random sequence is that first the researcher selects one of the numbers with his eyes closed and then moves in the right direction. Odd numbers are considered for intervention and even numbers are for control. Random concealment is also performed using sequentially numbered sealed opaque envelopes (SNOSE). 3 COVID-19. Intervention 1: Intervention group: Patients in the intervention group, in addition to standard medication (serum therapy, analgesics, antipyretic, and vitamine), take oral Favipiravir at a dose of 1600 mg every 12 hours for the first day and then 600 mg every 4 hours for 4 days. Favipiravir used is made by Abidi Pharmaceutical Company. Intervention 2: Control group: Patients in the control group receive symptomatic and supportive treatment (analgesic, antipyretic and vitamin) according to the national protocol. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.